Preparing for a future that includes telehealth means considering revenue streams, ROI, facility planning and other factors.
As the nation reopens amid the COVID-19 pandemic and patients return to doctors’ offices in-person, demand remains high for telehealth visits. According to a report earlier this year, virtual health care visits in the U.S. are on pace to top a record 1 billion by year’s end. What makes that statistic all the more remarkable is that just 24% of healthcare programs in the U.S. had an existing virtual health care program at the start of 2020.
This year’s rapid increase in demand for telehealth has been borne out of necessity because in-person patient visits were quickly deemed unsafe or not feasible in many parts of the country because of the COVID-19 pandemic. However, prior rules and regulations pertaining to telehealth, such as those regarding HIPAA regulations and payer coverage standards, were relaxed to encourage telehealth use. Providers and patients quickly cast aside any prior concerns they may have had about telehealth quality, efficacy and ease of use, particularly for using telehealth to resolve pandemic-related health concerns. Of the billion-plus telehealth visits projected for 2020, 90% are related to COVID-19.
It remains to be seen if the relaxed regulatory and payer standards for telehealth will continue.
Liz Townes
Many providers are, understandably, hesitant to invest further in telehealth, preferring to see what CMS and other payers will decide to do long term regarding telehealth visit rules and reimbursement standards.
That doesn’t mean, however, that you should let your telehealth plans languish.
Here are six factors to consider when charting your organization’s long-term telehealth strategy:
Ongoing high demand. As society reopens, and providers and patients again have the option of office visits, the demand for telehealth is still expected to remain high. A 2020 study forecasts a sevenfold increase in telehealth demand by 2025, which would be a compound growth rate of more than 38% annually. You will want to monitor regulation changes closely to ascertain how future demand for your telehealth services will be impacted, and prepare accordingly.
Reimbursement rates. At the start of the pandemic, many organizations struggled to obtain full payment for telehealth visits due to a lack of payment parity between telehealth and in-clinic visits, and varying policies by state and plan. In response, CMS and some private payers announced plans for telehealth payment parity during the pandemic. You can expect that these policies will likely shift anew. As revised telehealth reimbursement rules are lifted, it will be critical to continue to monitor all coding and billing policies closely to ensure you’re able to maximize your payments going forward.
Revenue impact. Will telehealth become an additive revenue stream for you, or remain an offset revenue stream? While the answer to this question partly depends on regulations and payer decisions, there is also significant unmet demand in some areas of clinical care, such as in behavioral health. As more is known long term about telehealth regulations and coverage, you should decide how you want to strategically and financially position telehealth in your organization.
Technology changes. In response to the pandemic, the Department of Health and Human Services relaxed HIPAA rules to allow providers to conduct telehealth visits via common video applications such as FaceTime, Skype and Zoom. HIPAA rules are expected to be restored, so providers who have relied on these applications to meet demand during the pandemic need to consider what technology to use in the future, and how to fund it.
What will be the preferred telehealth technologies of the future? Keep in mind that many providers used nonsecure consumer video applications either because some patients had trouble accessing providers’ secure telehealth applications or because these secure applications could not handle the increased patient demand. In assessing future telehealth technology needs, consider the likelihood of a number of new vendors entering the market, which should drive down costs but also make vendor selection more challenging. To ensure you can get the optimal solution in place as soon as possible, consider the added value of employing an experienced and objective resource for system selection and implementation, based on Agile methodology.
Return on investment – If you’ve been actively using telehealth throughout the pandemic, you’ll want to ensure you’ve amassed data throughout this time to help determine your return on investment (ROI). Your past ROI data related to telehealth will prove invaluable as you seek to forecast future ROI in order to inform your decision-making about the magnitude of your future telehealth investments. You may also wish to expand your definition of ROI to also factor in the value of telehealth as a competitive differentiator for your organization.
Facility planning – Your projected telehealth use will also impact your future facility needs, and you will want to plan accordingly. For example, if your organization is thinking about expanding its services, might it be possible to meet increased patient demand relying in part on telehealth? That way, you may not need to expand your existing ambulatory footprint. Organizations that historically planned two exam rooms per provider may now see an opportunity to plan for just 1.8 or 1.6 exam rooms for each provider, freeing up exam room space for other growth. You should also consider how to adjust your facility design to accommodate private, non-exam space for telehealth video visits. This will be especially important for clinics that have already been driving toward greater office space efficiency and clinical collaboration by eliminating physicians’ private offices.
Considering that full-scale telehealth is still new to many if not most providers, and that regulations, reimbursement rules and even technologies for telehealth are still in a state of flux, you will likely have many important future decisions to make regarding your telehealth offerings. There is only one absolute certainty: Telehealth is here to stay.
Liz Townes is a consultant with Freed Associates, a California-based healthcare management consulting firm.
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
Skyrizi Overtakes Humira in U.S. Sales Numbers
November 8th 2024For the first time, Skyrizi has replaced Humira as AbbVie’s sales driver, largely due to companies encouraging “product hopping” to avoid competition, creating concerns for the sustainability of the burgeoning adalimumab biosimilar market.
Read More